Clinical Trial Update: Safety and Tolerance of Increased Doses of HRS-5346 Tablets in Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 trial assessing safety and tolerability of higher doses of HRS-5346 in healthy subjects.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Disorders of Lipoprotein Metabolism

Drugs mentioned

• HRS-5346

Snippet

Sponsor: Shandong Suncadia Medicine Co., Ltd. | Conditions: Lipoprotein Disorder Disease | Phase 1 | Status: COMPLETED